Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

400 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis.
Magni R, Espina BH, Shah K, Lepene B, Mayuga C, Douglas TA, Espina V, Rucker S, Dunlap R, Petricoin EF, Kilavos MF, Poretz DM, Irwin GR, Shor SM, Liotta LA, Luchini A. Magni R, et al. Among authors: petricoin ef. J Transl Med. 2015 Nov 4;13:346. doi: 10.1186/s12967-015-0701-z. J Transl Med. 2015. PMID: 26537892 Free PMC article.
Synthesis and characterization of hydrogel particles containing Cibacron Blue F3G-A.
Patanarut A, Luchini A, Botterell PJ, Mohan A, Longo C, Vorster P, Petricoin EF 3rd, Liotta LA, Bishop B. Patanarut A, et al. Among authors: petricoin ef 3rd. Colloids Surf A Physicochem Eng Asp. 2010 Jun;362(1-3):8-19. doi: 10.1016/j.colsurfa.2010.03.023. Colloids Surf A Physicochem Eng Asp. 2010. PMID: 20871782 Free PMC article.
Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers.
Tamburro D, Fredolini C, Espina V, Douglas TA, Ranganathan A, Ilag L, Zhou W, Russo P, Espina BH, Muto G, Petricoin EF 3rd, Liotta LA, Luchini A. Tamburro D, et al. Among authors: petricoin ef 3rd. J Am Chem Soc. 2011 Nov 30;133(47):19178-88. doi: 10.1021/ja207515j. Epub 2011 Nov 3. J Am Chem Soc. 2011. PMID: 21999289 Free PMC article.
Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins.
Raiszadeh MM, Ross MM, Russo PS, Schaepper MA, Zhou W, Deng J, Ng D, Dickson A, Dickson C, Strom M, Osorio C, Soeprono T, Wulfkuhle JD, Petricoin EF, Liotta LA, Kirsch WM. Raiszadeh MM, et al. Among authors: petricoin ef. J Proteome Res. 2012 Apr 6;11(4):2127-39. doi: 10.1021/pr2007957. Epub 2012 Feb 27. J Proteome Res. 2012. PMID: 22256890 Free PMC article.
The Warburg Effect and Mass Spectrometry-based Proteomic Analysis.
Zhou W, Liotta LA, Petricoin EF. Zhou W, et al. Among authors: petricoin ef. Cancer Genomics Proteomics. 2017 Jul-Aug;14(4):211-218. doi: 10.21873/cgp.20032. Cancer Genomics Proteomics. 2017. PMID: 28647695 Free PMC article. Review.
Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes.
Magni R, Rruga F, Alsaab FM, Sharif S, Howard M, Espina V, Kim B, Lepene B, Lee G, Alayouni MA, Steinberg H, Araujo R, Kashanchi F, Riccardi F, Morreira S, Araujo A, Poli F, Jaganath D, Semitala FC, Worodria W, Andama A, Choudhary A, Honnen WJ, Petricoin EF 3rd, Cattamanchi A, Colombatti R, de Waard JH, Oberhelman R, Pinter A, Gilman RH, Liotta LA, Luchini A. Magni R, et al. Among authors: petricoin ef 3rd. Sci Rep. 2020 Aug 18;10(1):13944. doi: 10.1038/s41598-020-70669-9. Sci Rep. 2020. PMID: 32811861 Free PMC article.
Reverse Phase Protein Microarrays.
Baldelli E, Calvert V, Hodge A, VanMeter A, Petricoin EF 3rd, Pierobon M. Baldelli E, et al. Among authors: petricoin ef 3rd. Methods Mol Biol. 2017;1606:149-169. doi: 10.1007/978-1-4939-6990-6_11. Methods Mol Biol. 2017. PMID: 28502000
Mass Spectrometry-Based Biomarker Discovery.
Zhou W, Petricoin EF 3rd, Longo C. Zhou W, et al. Among authors: petricoin ef 3rd. Methods Mol Biol. 2017;1606:297-311. doi: 10.1007/978-1-4939-6990-6_19. Methods Mol Biol. 2017. PMID: 28502008
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection.
Fredolini C, Pathak KV, Paris L, Chapple KM, Tsantilas KA, Rosenow M, Tegeler TJ, Garcia-Mansfield K, Tamburro D, Zhou W, Russo P, Massarut S, Facchiano F, Belluco C, De Maria R, Garaci E, Liotta L, Petricoin EF, Pirrotte P. Fredolini C, et al. Among authors: petricoin ef. Breast Cancer Res. 2020 Dec 2;22(1):135. doi: 10.1186/s13058-020-01373-9. Breast Cancer Res. 2020. PMID: 33267867 Free PMC article.
Reverse-phase protein microarrays.
Pierobon M, Vanmeter AJ, Moroni N, Galdi F, Petricoin EF 3rd. Pierobon M, et al. Among authors: petricoin ef 3rd. Methods Mol Biol. 2012;823:215-35. doi: 10.1007/978-1-60327-216-2_14. Methods Mol Biol. 2012. PMID: 22081348
Preparation and use of reverse protein microarrays.
Pin E, Federici G, Petricoin EF 3rd. Pin E, et al. Among authors: petricoin ef 3rd. Curr Protoc Protein Sci. 2014 Feb 3;75:27.7.1-27.7.29. doi: 10.1002/0471140864.ps2707s75. Curr Protoc Protein Sci. 2014. PMID: 24510676
Molecular diagnostics: an FDA perspective.
Ardekani AM, Petricoin EF 3rd, Hackett JL. Ardekani AM, et al. Among authors: petricoin ef 3rd. Expert Rev Mol Diagn. 2003 Mar;3(2):129-40. doi: 10.1586/14737159.3.2.129. Expert Rev Mol Diagn. 2003. PMID: 12647991
Clinical applications of proteomics.
Petricoin EF, Liotta LA. Petricoin EF, et al. J Nutr. 2003 Jul;133(7 Suppl):2476S-2484S. doi: 10.1093/jn/133.7.2476S. J Nutr. 2003. PMID: 12840227 Review.
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.
Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee JK, Espina V, Munson PJ, Petricoin E 3rd, Liotta LA, Weinstein JN. Nishizuka S, et al. Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14229-34. doi: 10.1073/pnas.2331323100. Epub 2003 Nov 17. Proc Natl Acad Sci U S A. 2003. PMID: 14623978 Free PMC article.
Clinical proteomics: application at the bedside.
Petricoin EF, Liotta LA. Petricoin EF, et al. Contrib Nephrol. 2004;141:93-103. doi: 10.1159/000074591. Contrib Nephrol. 2004. PMID: 14650227 Review. No abstract available.
A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples.
Lopez MF, Mikulskis A, Kuzdzal S, Golenko E, Petricoin EF 3rd, Liotta LA, Patton WF, Whiteley GR, Rosenblatt K, Gurnani P, Nandi A, Neill S, Cullen S, O'Gorman M, Sarracino D, Lynch C, Johnson A, Mckenzie W, Fishman D. Lopez MF, et al. Among authors: petricoin ef 3rd. Clin Chem. 2007 Jun;53(6):1067-74. doi: 10.1373/clinchem.2006.080721. Epub 2007 Apr 26. Clin Chem. 2007. PMID: 17463175
A portrait of tissue phosphoprotein stability in the clinical tissue procurement process.
Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: petricoin ef 3rd. Mol Cell Proteomics. 2008 Oct;7(10):1998-2018. doi: 10.1074/mcp.M700596-MCP200. Epub 2008 Jul 30. Mol Cell Proteomics. 2008. PMID: 18667411 Free PMC article.
Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
VanMeter AJ, Rodriguez AS, Bowman ED, Jen J, Harris CC, Deng J, Calvert VS, Silvestri A, Fredolini C, Chandhoke V, Petricoin EF 3rd, Liotta LA, Espina V. VanMeter AJ, et al. Among authors: petricoin ef 3rd. Mol Cell Proteomics. 2008 Oct;7(10):1902-24. doi: 10.1074/mcp.M800204-MCP200. Epub 2008 Aug 6. Mol Cell Proteomics. 2008. PMID: 18687633 Free PMC article.
Proteomics in laboratory medicine. Preface.
Petricoin EF. Petricoin EF. Clin Lab Med. 2009 Mar;29(1):xiii-xiv. doi: 10.1016/j.cll.2009.02.002. Clin Lab Med. 2009. PMID: 19389546 No abstract available.
Concentration and Preservation of Very Low Abundance Biomarkers in Urine, such as Human Growth Hormone (hGH), by Cibacron Blue F3G-A Loaded Hydrogel Particles.
Fredolini C, Meani F, Reeder KA, Rucker S, Patanarut A, Botterell PJ, Bishop B, Longo C, Espina V, Petricoin EF 3rd, Liotta LA, Luchini A. Fredolini C, et al. Among authors: petricoin ef 3rd. Nano Res. 2008 Dec;1(6):502-518. doi: 10.1007/s12274-008-8054-z. Nano Res. 2008. PMID: 20467576 Free PMC article.
Mass spectrometry-based characterization of the vitreous phosphoproteome.
Tamburro D, Facchiano F, Petricoin EF, Liotta LA, Zhou W. Tamburro D, et al. Among authors: petricoin ef. Proteomics Clin Appl. 2010 Nov;4(10-11):839-46. doi: 10.1002/prca.201000032. Epub 2010 Oct 4. Proteomics Clin Appl. 2010. PMID: 21137027 Free PMC article.
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.
Ibarra-Drendall C, Troch MM, Barry WT, Broadwater G, Petricoin EF 3rd, Wulfkuhle J, Liotta LA, Lem S, Baker JC Jr, Ford AC, Wilke LG, Zalles C, Kuderer NM, Hoffman AW, Shivraj M, Mehta P, Williams J, Tolbert N, Lee LW, Pilie PG, Yu D, Seewaldt VL. Ibarra-Drendall C, et al. Among authors: petricoin ef 3rd. Breast Cancer Res Treat. 2012 Apr;132(2):487-98. doi: 10.1007/s10549-011-1609-9. Epub 2011 Jun 7. Breast Cancer Res Treat. 2012. PMID: 21647677 Free PMC article.
Mass spectrometry-based biomarker discovery.
Zhou W, Petricoin EF 3rd, Longo C. Zhou W, et al. Among authors: petricoin ef 3rd. Methods Mol Biol. 2012;823:251-64. doi: 10.1007/978-1-60327-216-2_16. Methods Mol Biol. 2012. PMID: 22081350
The role of IKKβ in Venezuelan equine encephalitis virus infection.
Amaya M, Voss K, Sampey G, Senina S, de la Fuente C, Mueller C, Calvert V, Kehn-Hall K, Carpenter C, Kashanchi F, Bailey C, Mogelsvang S, Petricoin E, Narayanan A. Amaya M, et al. PLoS One. 2014 Feb 19;9(2):e86745. doi: 10.1371/journal.pone.0086745. eCollection 2014. PLoS One. 2014. PMID: 24586253 Free PMC article.
Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.
Akbani R, Becker KF, Carragher N, Goldstein T, de Koning L, Korf U, Liotta L, Mills GB, Nishizuka SS, Pawlak M, Petricoin EF 3rd, Pollard HB, Serrels B, Zhu J. Akbani R, et al. Among authors: petricoin ef 3rd. Mol Cell Proteomics. 2014 Jul;13(7):1625-43. doi: 10.1074/mcp.O113.034918. Epub 2014 Apr 28. Mol Cell Proteomics. 2014. PMID: 24777629 Free PMC article.
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab.
Pierobon M, Silvestri A, Spira A, Reeder A, Pin E, Banks S, Parasido E, Edmiston K, Liotta L, Petricoin E. Pierobon M, et al. J Proteome Res. 2014 Jun 6;13(6):2846-55. doi: 10.1021/pr401267m. Epub 2014 May 14. J Proteome Res. 2014. PMID: 24787230
Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion.
Falchi M, Varricchio L, Martelli F, Masiello F, Federici G, Zingariello M, Girelli G, Whitsett C, Petricoin EF 3rd, Moestrup SK, Zeuner A, Migliaccio AR. Falchi M, et al. Among authors: petricoin ef 3rd. Haematologica. 2015 Feb;100(2):178-87. doi: 10.3324/haematol.2014.114405. Epub 2014 Dec 22. Haematologica. 2015. PMID: 25533803 Free PMC article.
Role of Bruton's tyrosine kinase inhibitors in HIV-1-infected cells.
Guendel I, Iordanskiy S, Sampey GC, Van Duyne R, Calvert V, Petricoin E, Saifuddin M, Kehn-Hall K, Kashanchi F. Guendel I, et al. J Neurovirol. 2015 Jun;21(3):257-75. doi: 10.1007/s13365-015-0323-5. Epub 2015 Feb 12. J Neurovirol. 2015. PMID: 25672887 Free PMC article.
Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine.
Baldelli E, Haura EB, Crinò L, Cress DW, Ludovini V, Schabath MB, Liotta LA, Petricoin EF, Pierobon M. Baldelli E, et al. Among authors: petricoin ef. Proteomics Clin Appl. 2015 Oct;9(9-10):928-37. doi: 10.1002/prca.201400056. Epub 2015 Mar 24. Proteomics Clin Appl. 2015. PMID: 25676683 Free PMC article.
Multifactorial analysis of conditional reprogramming of human keratinocytes.
Ligaba SB, Khurana A, Graham G, Krawczyk E, Jablonski S, Petricoin EF, Glazer RI, Upadhyay G. Ligaba SB, et al. Among authors: petricoin ef. PLoS One. 2015 Feb 25;10(2):e0116755. doi: 10.1371/journal.pone.0116755. eCollection 2015. PLoS One. 2015. PMID: 25714835 Free PMC article.
Host response during Yersinia pestis infection of human bronchial epithelial cells involves negative regulation of autophagy and suggests a modulation of survival-related and cellular growth pathways.
Alem F, Yao K, Lane D, Calvert V, Petricoin EF, Kramer L, Hale ML, Bavari S, Panchal RG, Hakami RM. Alem F, et al. Among authors: petricoin ef. Front Microbiol. 2015 Feb 13;6:50. doi: 10.3389/fmicb.2015.00050. eCollection 2015. Front Microbiol. 2015. PMID: 25762983 Free PMC article.
Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin.
Bermudez Y, Stratton SP, Curiel-Lewandrowski C, Warneke J, Hu C, Bowden GT, Dickinson SE, Dong Z, Bode AM, Saboda K, Brooks CA, Petricoin EF 3rd, Hurst CA, Alberts DS, Einspahr JG. Bermudez Y, et al. Among authors: petricoin ef 3rd. Cancer Prev Res (Phila). 2015 Aug;8(8):720-8. doi: 10.1158/1940-6207.CAPR-14-0407. Epub 2015 Jun 1. Cancer Prev Res (Phila). 2015. PMID: 26031292 Free PMC article. Clinical Trial.
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.
Blanco FF, Jimbo M, Wulfkuhle J, Gallagher I, Deng J, Enyenihi L, Meisner-Kober N, Londin E, Rigoutsos I, Sawicki JA, Risbud MV, Witkiewicz AK, McCue PA, Jiang W, Rui H, Yeo CJ, Petricoin E, Winter JM, Brody JR. Blanco FF, et al. Oncogene. 2016 May;35(19):2529-41. doi: 10.1038/onc.2015.325. Epub 2015 Sep 21. Oncogene. 2016. PMID: 26387536 Free PMC article.
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.
Hayes TK, Neel NF, Hu C, Gautam P, Chenard M, Long B, Aziz M, Kassner M, Bryant KL, Pierobon M, Marayati R, Kher S, George SD, Xu M, Wang-Gillam A, Samatar AA, Maitra A, Wennerberg K, Petricoin EF 3rd, Yin HH, Nelkin B, Cox AD, Yeh JJ, Der CJ. Hayes TK, et al. Among authors: petricoin ef 3rd. Cancer Cell. 2016 Jan 11;29(1):75-89. doi: 10.1016/j.ccell.2015.11.011. Epub 2015 Dec 24. Cancer Cell. 2016. PMID: 26725216 Free PMC article.
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Sereni MI, Baldelli E, Gambara G, Ravaggi A, Hodge KA, Alberts DS, Guillen-Rodriguez JM, Dong T, Memo M, Odicino F, Angioli R, Liotta LA, Pecorelli SL, Petricoin EF, Pierobon M. Sereni MI, et al. Among authors: petricoin ef. Br J Cancer. 2017 Aug 8;117(4):494-502. doi: 10.1038/bjc.2017.195. Epub 2017 Jun 29. Br J Cancer. 2017. PMID: 28664915 Free PMC article.
Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma.
deCarvalho AC, Kim H, Poisson LM, Winn ME, Mueller C, Cherba D, Koeman J, Seth S, Protopopov A, Felicella M, Zheng S, Multani A, Jiang Y, Zhang J, Nam DH, Petricoin EF, Chin L, Mikkelsen T, Verhaak RGW. deCarvalho AC, et al. Among authors: petricoin ef. Nat Genet. 2018 May;50(5):708-717. doi: 10.1038/s41588-018-0105-0. Epub 2018 Apr 23. Nat Genet. 2018. PMID: 29686388 Free PMC article.
An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease.
Younossi ZM, Karrar A, Pierobon M, Birerdinc A, Stepanova M, Abdelatif D, Younoszai Z, Jeffers T, Felix S, Jeiran K, Hodge A, Zhou W, Monge F, Alaparthi L, Chandhoke V, Goodman ZD, Petricoin EF. Younossi ZM, et al. Among authors: petricoin ef. BMC Med. 2018 Sep 12;16(1):170. doi: 10.1186/s12916-018-1136-1. BMC Med. 2018. PMID: 30205811 Free PMC article.
Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells.
Hau AM, Gupta S, Leivo MZ, Nakashima K, Macias J, Zhou W, Hodge A, Wulfkuhle J, Conkright B, Bhuvaneshwar K, Rao S, Madhavan S, Petricoin EF 3rd, Hansel DE. Hau AM, et al. Among authors: petricoin ef 3rd. Am J Pathol. 2019 Sep;189(9):1846-1862. doi: 10.1016/j.ajpath.2019.05.010. Epub 2019 Jun 11. Am J Pathol. 2019. PMID: 31199921 Free article.
Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.
Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, Panelli MC, Perricone MA, Petricoin EF, Sauter G, Scheibenbogen C, Shivers SC, Taylor DL, Weinstein JN, Whiteside TL. Lotze MT, et al. Among authors: petricoin ef. J Immunother. 2005 Mar-Apr;28(2):79-119. doi: 10.1097/01.cji.0000154251.20125.2e. J Immunother. 2005. PMID: 15725954
Analysis of albumin-associated peptides and proteins from ovarian cancer patients.
Lowenthal MS, Mehta AI, Frogale K, Bandle RW, Araujo RP, Hood BL, Veenstra TD, Conrads TP, Goldsmith P, Fishman D, Petricoin EF 3rd, Liotta LA. Lowenthal MS, et al. Among authors: petricoin ef 3rd. Clin Chem. 2005 Oct;51(10):1933-45. doi: 10.1373/clinchem.2005.052944. Epub 2005 Aug 11. Clin Chem. 2005. PMID: 16099937
Modeling of protein signaling networks in clinical proteomics.
Geho DH, Petricoin EF, Liotta LA, Araujo RP. Geho DH, et al. Among authors: petricoin ef. Cold Spring Harb Symp Quant Biol. 2005;70:517-24. doi: 10.1101/sqb.2005.70.022. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869790 Review.
Physicochemically modified silicon as a substrate for protein microarrays.
Nijdam AJ, Ming-Cheng Cheng M, Geho DH, Fedele R, Herrmann P, Killian K, Espina V, Petricoin EF 3rd, Liotta LA, Ferrari M. Nijdam AJ, et al. Among authors: petricoin ef 3rd. Biomaterials. 2007 Jan;28(3):550-8. doi: 10.1016/j.biomaterials.2006.08.051. Epub 2006 Sep 20. Biomaterials. 2007. PMID: 16987550
Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival.
Espina V, Mariani BD, Gallagher RI, Tran K, Banks S, Wiedemann J, Huryk H, Mueller C, Adamo L, Deng J, Petricoin EF, Pastore L, Zaman S, Menezes G, Mize J, Johal J, Edmiston K, Liotta LA. Espina V, et al. Among authors: petricoin ef. PLoS One. 2010 Apr 20;5(4):e10240. doi: 10.1371/journal.pone.0010240. PLoS One. 2010. PMID: 20421921 Free PMC article.
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays.
Prakash A, Rezai T, Krastins B, Sarracino D, Athanas M, Russo P, Ross MM, Zhang H, Tian Y, Kulasingam V, Drabovich AP, Smith C, Batruch I, Liotta L, Petricoin E, Diamandis EP, Chan DW, Lopez MF. Prakash A, et al. J Proteome Res. 2010 Dec 3;9(12):6678-88. doi: 10.1021/pr100821m. Epub 2010 Nov 2. J Proteome Res. 2010. PMID: 20945832
Stratification of clear cell renal cell carcinoma by signaling pathway analysis.
Cremona M, Espina V, Caccia D, Veneroni S, Colecchia M, Pierobon M, Deng J, Mueller C, Procopio G, Lanzi C, Daidone MG, Cho WC, Petricoin EF, Liotta L, Bongarzone I. Cremona M, et al. Among authors: petricoin ef. Expert Rev Proteomics. 2014 Apr;11(2):237-49. doi: 10.1586/14789450.2014.893193. Epub 2014 Feb 27. Expert Rev Proteomics. 2014. PMID: 24575852
Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin.
Dickinson SE, Janda J, Criswell J, Blohm-Mangone K, Olson ER, Liu Z, Barber C, Petricoin EF 3rd, Calvert VS, Einspahr J, Dickinson JE, Stratton SP, Curiel-Lewandrowski C, Saboda K, Hu C, Bode AM, Dong Z, Alberts DS, Timothy Bowden G. Dickinson SE, et al. Among authors: petricoin ef 3rd. Cancer Prev Res (Phila). 2016 Mar;9(3):215-24. doi: 10.1158/1940-6207.CAPR-15-0419. Epub 2016 Jan 22. Cancer Prev Res (Phila). 2016. PMID: 26801880 Free PMC article.
Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin.
Janda J, Burkett NB, Blohm-Mangone K, Huang V, Curiel-Lewandrowski C, Alberts DS, Petricoin EF 3rd, Calvert VS, Einspahr J, Dong Z, Bode AM, Wondrak GT, Dickinson SE. Janda J, et al. Among authors: petricoin ef 3rd. Photochem Photobiol. 2016 Nov;92(6):816-825. doi: 10.1111/php.12659. Epub 2016 Dec 8. Photochem Photobiol. 2016. PMID: 27859308 Free PMC article.
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.
Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, Gunda V, Pierobon M, Waters AM, George SD, Tomar G, Papke B, Hobbs GA, Yan L, Hayes TK, Diehl JN, Goode GD, Chaika NV, Wang Y, Zhang GF, Witkiewicz AK, Knudsen ES, Petricoin EF 3rd, Singh PK, Macdonald JM, Tran NL, Lyssiotis CA, Ying H, Kimmelman AC, Cox AD, Der CJ. Bryant KL, et al. Among authors: petricoin ef 3rd. Nat Med. 2019 Apr;25(4):628-640. doi: 10.1038/s41591-019-0368-8. Epub 2019 Mar 4. Nat Med. 2019. PMID: 30833752 Free PMC article.
Nanoparticles: potential biomarker harvesters.
Geho DH, Jones CD, Petricoin EF, Liotta LA. Geho DH, et al. Among authors: petricoin ef. Curr Opin Chem Biol. 2006 Feb;10(1):56-61. doi: 10.1016/j.cbpa.2006.01.003. Epub 2006 Jan 18. Curr Opin Chem Biol. 2006. PMID: 16413816 Review.
Laser-capture microdissection.
Espina V, Wulfkuhle JD, Calvert VS, VanMeter A, Zhou W, Coukos G, Geho DH, Petricoin EF 3rd, Liotta LA. Espina V, et al. Among authors: petricoin ef 3rd. Nat Protoc. 2006;1(2):586-603. doi: 10.1038/nprot.2006.85. Nat Protoc. 2006. PMID: 17406286
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.
Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, Fridman WH, Hirohashi Y, Imai K, Jacobson J, Jinushi M, Kanamoto A, Kashani-Sabet M, Kato K, Kawakami Y, Kirkwood JM, Kleen TO, Lehmann PV, Liotta L, Lotze MT, Maio M, Malyguine A, Masucci G, Matsubara H, Mayrand-Chung S, Nakamura K, Nishikawa H, Palucka AK, Petricoin EF, Pos Z, Ribas A, Rivoltini L, Sato N, Shiku H, Slingluff CL, Streicher H, Stroncek DF, Takeuchi H, Toyota M, Wada H, Wu X, Wulfkuhle J, Yaguchi T, Zeskind B, Zhao Y, Zocca MB, Marincola FM. Tahara H, et al. Among authors: petricoin ef. J Transl Med. 2009 Jun 17;7:45. doi: 10.1186/1479-5876-7-45. J Transl Med. 2009. PMID: 19534815 Free PMC article.
Quantum dots for biomedical applications.
Signore M, Liotta LA, Maria RD, Petricoin EF. Signore M, et al. Among authors: petricoin ef. Expert Opin Med Diagn. 2008 Mar;2(3):315-22. doi: 10.1517/17530059.2.3.315. Expert Opin Med Diagn. 2008. PMID: 23495661
Combining markers with and without the limit of detection.
Dong T, Liu CC, Petricoin EF, Tang LL. Dong T, et al. Among authors: petricoin ef. Stat Med. 2014 Apr 15;33(8):1307-20. doi: 10.1002/sim.6027. Epub 2013 Oct 17. Stat Med. 2014. PMID: 24132938 Free PMC article.
Cancer metabolism and mass spectrometry-based proteomics.
Zhou W, Liotta LA, Petricoin EF. Zhou W, et al. Among authors: petricoin ef. Cancer Lett. 2015 Jan 28;356(2 Pt A):176-83. doi: 10.1016/j.canlet.2013.11.003. Epub 2013 Nov 18. Cancer Lett. 2015. PMID: 24262660 Review.
Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.
Ceglia I, Dueck AC, Masiello F, Martelli F, He W, Federici G, Petricoin EF 3rd, Zeuner A, Iancu-Rubin C, Weinberg R, Hoffman R, Mascarenhas J, Migliaccio AR. Ceglia I, et al. Among authors: petricoin ef 3rd. Exp Hematol. 2016 Dec;44(12):1138-1155.e4. doi: 10.1016/j.exphem.2016.08.007. Epub 2016 Aug 31. Exp Hematol. 2016. PMID: 27592389 Free PMC article.
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
Guo Z, Sevrioukova IF, Denisov IG, Zhang X, Chiu TL, Thomas DG, Hanse EA, Cuellar RAD, Grinkova YV, Langenfeld VW, Swedien DS, Stamschror JD, Alvarez J, Luna F, Galván A, Bae YK, Wulfkuhle JD, Gallagher RI, Petricoin EF Rd, Norris B, Flory CM, Schumacher RJ, O'Sullivan MG, Cao Q, Chu H, Lipscomb JD, Atkins WM, Gupta K, Kelekar A, Blair IA, Capdevila JH, Falck JR, Sligar SG, Poulos TL, Georg GI, Ambrose E, Potter DA. Guo Z, et al. Among authors: petricoin ef rd. Cell Chem Biol. 2017 Oct 19;24(10):1259-1275.e6. doi: 10.1016/j.chembiol.2017.08.009. Epub 2017 Sep 14. Cell Chem Biol. 2017. PMID: 28919040 Free PMC article.
Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in Glioblastoma.
Cruickshanks N, Zhang Y, Hine S, Gibert M, Yuan F, Oxford M, Grello C, Pahuski M, Dube C, Guessous F, Wang B, Deveau C, Saoud K, Gallagher I, Wulfkuhle J, Schiff D, Phan S, Petricoin E, Abounader R. Cruickshanks N, et al. Clin Cancer Res. 2019 Jan 15;25(2):663-673. doi: 10.1158/1078-0432.CCR-18-0926. Epub 2018 Sep 10. Clin Cancer Res. 2019. PMID: 30201763 Free PMC article.
Molecular profiling of human cancer.
Liotta L, Petricoin E. Liotta L, et al. Nat Rev Genet. 2000 Oct;1(1):48-56. doi: 10.1038/35049567. Nat Rev Genet. 2000. PMID: 11262874 Review.
Breast cancer growth prevention by statins.
Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC. Campbell MJ, et al. Among authors: petricoin ef. Cancer Res. 2006 Sep 1;66(17):8707-14. doi: 10.1158/0008-5472.CAN-05-4061. Cancer Res. 2006. PMID: 16951186
Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation.
Luchini A, Geho DH, Bishop B, Tran D, Xia C, Dufour RL, Jones CD, Espina V, Patanarut A, Zhou W, Ross MM, Tessitore A, Petricoin EF 3rd, Liotta LA. Luchini A, et al. Among authors: petricoin ef 3rd. Nano Lett. 2008 Jan;8(1):350-61. doi: 10.1021/nl072174l. Epub 2007 Dec 13. Nano Lett. 2008. PMID: 18076201 Free PMC article.
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.
Fredolini C, Meani F, Luchini A, Zhou W, Russo P, Ross M, Patanarut A, Tamburro D, Gambara G, Ornstein D, Odicino F, Ragnoli M, Ravaggi A, Novelli F, Collura D, D'Urso L, Muto G, Belluco C, Pecorelli S, Liotta L, Petricoin EF 3rd. Fredolini C, et al. Among authors: petricoin ef 3rd. AAPS J. 2010 Dec;12(4):504-18. doi: 10.1208/s12248-010-9211-3. Epub 2010 Jun 12. AAPS J. 2010. PMID: 20549403 Free PMC article.
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples.
Frederick MJ, VanMeter AJ, Gadhikar MA, Henderson YC, Yao H, Pickering CC, Williams MD, El-Naggar AK, Sandulache V, Tarco E, Myers JN, Clayman GL, Liotta LA, Petricoin EF 3rd, Calvert VS, Fodale V, Wang J, Weber RS. Frederick MJ, et al. Among authors: petricoin ef 3rd. Am J Pathol. 2011 Feb;178(2):548-71. doi: 10.1016/j.ajpath.2010.10.044. Am J Pathol. 2011. PMID: 21281788 Free PMC article.
Homologous control of protein signaling networks.
Napoletani D, Signore M, Sauer T, Liotta L, Petricoin E. Napoletani D, et al. J Theor Biol. 2011 Jun 21;279(1):29-43. doi: 10.1016/j.jtbi.2011.03.020. Epub 2011 Mar 23. J Theor Biol. 2011. PMID: 21439301
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors.
Xia W, Liu Z, Zong R, Liu L, Zhao S, Bacus SS, Mao Y, He J, Wulfkuhle JD, Petricoin EF 3rd, Osada T, Yang XY, Hartman ZC, Clay TM, Blackwell KL, Lyerly HK, Spector NL. Xia W, et al. Among authors: petricoin ef 3rd. Mol Cancer Ther. 2011 Aug;10(8):1367-74. doi: 10.1158/1535-7163.MCT-10-0991. Epub 2011 Jun 14. Mol Cancer Ther. 2011. PMID: 21673090 Free PMC article.
Asymmetric cancer cell division regulated by AKT.
Dey-Guha I, Wolfer A, Yeh AC, G Albeck J, Darp R, Leon E, Wulfkuhle J, Petricoin EF 3rd, Wittner BS, Ramaswamy S. Dey-Guha I, et al. Among authors: petricoin ef 3rd. Proc Natl Acad Sci U S A. 2011 Aug 2;108(31):12845-50. doi: 10.1073/pnas.1109632108. Epub 2011 Jul 14. Proc Natl Acad Sci U S A. 2011. PMID: 21757645 Free PMC article.
Reverse phase protein microarrays for clinical applications.
Pierobon M, Belluco C, Liotta LA, Petricoin EF 3rd. Pierobon M, et al. Among authors: petricoin ef 3rd. Methods Mol Biol. 2011;785:3-12. doi: 10.1007/978-1-61779-286-1_1. Methods Mol Biol. 2011. PMID: 21901589
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
Zuurbier L, Petricoin EF 3rd, Vuerhard MJ, Calvert V, Kooi C, Buijs-Gladdines JG, Smits WK, Sonneveld E, Veerman AJ, Kamps WA, Horstmann M, Pieters R, Meijerink JP. Zuurbier L, et al. Among authors: petricoin ef 3rd. Haematologica. 2012 Sep;97(9):1405-13. doi: 10.3324/haematol.2011.059030. Epub 2012 Apr 4. Haematologica. 2012. PMID: 22491738 Free PMC article.
Quantifying the CDK inhibitor VMY-1-103's activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI.
Sirajuddin P, Das S, Ringer L, Rodriguez OC, Sivakumar A, Lee YC, Üren A, Fricke ST, Rood B, Ozcan A, Wang SS, Karam S, Yenugonda V, Salinas P, Petricoin E 3rd, Pishvaian M, Lisanti MP, Wang Y, Schlegel R, Moasser B, Albanese C. Sirajuddin P, et al. Cell Cycle. 2012 Oct 15;11(20):3801-9. doi: 10.4161/cc.21988. Epub 2012 Sep 14. Cell Cycle. 2012. PMID: 22983062 Free PMC article.
Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera.
Hricik T, Federici G, Zeuner A, Alimena G, Tafuri A, Tirelli V, Varricchio L, Masiello F, Ciaffoni F, Vaglio S, Petricoin EF, Girelli G, Levine RL, Migliaccio AR. Hricik T, et al. Among authors: petricoin ef. Am J Hematol. 2013 Sep;88(9):723-9. doi: 10.1002/ajh.23487. Epub 2013 Jul 3. Am J Hematol. 2013. PMID: 23720412 Free PMC article.
Integrated genomic and epigenomic analysis of breast cancer brain metastasis.
Salhia B, Kiefer J, Ross JT, Metapally R, Martinez RA, Johnson KN, DiPerna DM, Paquette KM, Jung S, Nasser S, Wallstrom G, Tembe W, Baker A, Carpten J, Resau J, Ryken T, Sibenaller Z, Petricoin EF, Liotta LA, Ramanathan RK, Berens ME, Tran NL. Salhia B, et al. Among authors: petricoin ef. PLoS One. 2014 Jan 29;9(1):e85448. doi: 10.1371/journal.pone.0085448. eCollection 2014. PLoS One. 2014. PMID: 24489661 Free PMC article.
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis.
Bertacchini J, Guida M, Accordi B, Mediani L, Martelli AM, Barozzi P, Petricoin E 3rd, Liotta L, Milani G, Giordan M, Luppi M, Forghieri F, De Pol A, Cocco L, Basso G, Marmiroli S. Bertacchini J, et al. Leukemia. 2014 Nov;28(11):2197-205. doi: 10.1038/leu.2014.123. Epub 2014 Apr 4. Leukemia. 2014. PMID: 24699302
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer.
Jameson GS, Petricoin EF, Sachdev J, Liotta LA, Loesch DM, Anthony SP, Chadha MK, Wulfkuhle JD, Gallagher RI, Reeder KA, Pierobon M, Fulk MR, Cantafio NA, Dunetz B, Mikrut WD, Von Hoff DD, Robert NJ. Jameson GS, et al. Among authors: petricoin ef. Breast Cancer Res Treat. 2014 Oct;147(3):579-88. doi: 10.1007/s10549-014-3117-1. Epub 2014 Sep 11. Breast Cancer Res Treat. 2014. PMID: 25209003 Clinical Trial.
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
Sereni MI, Baldelli E, Gambara G, Deng J, Zanotti L, Bandiera E, Bignotti E, Ragnoli M, Tognon G, Ravaggi A, Meani F, Memo M, Angioli R, Liotta LA, Pecorelli SL, Petricoin E 3rd, Pierobon M. Sereni MI, et al. Proteomics. 2015 Jan;15(2-3):365-73. doi: 10.1002/pmic.201400214. Proteomics. 2015. PMID: 25311472
Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors.
Baldelli E, Bellezza G, Haura EB, Crinó L, Cress WD, Deng J, Ludovini V, Sidoni A, Schabath MB, Puma F, Vannucci J, Siggillino A, Liotta LA, Petricoin EF 3rd, Pierobon M. Baldelli E, et al. Among authors: petricoin ef 3rd. Oncotarget. 2015 Oct 20;6(32):32368-79. doi: 10.18632/oncotarget.5941. Oncotarget. 2015. PMID: 26468985 Free PMC article.
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
Pierobon M, Ramos C, Wong S, Hodge KA, Aldrich J, Byron S, Anthony SP, Robert NJ, Northfelt DW, Jahanzeb M, Vocila L, Wulfkuhle J, Gambara G, Gallagher RI, Dunetz B, Hoke N, Dong T, Craig DW, Cristofanilli M, Leyland-Jones B, Liotta LA, O'Shaughnessy JA, Carpten JD, Petricoin EF. Pierobon M, et al. Among authors: petricoin ef. Clin Cancer Res. 2017 Aug 15;23(16):4919-4928. doi: 10.1158/1078-0432.CCR-16-2656. Epub 2017 Apr 26. Clin Cancer Res. 2017. PMID: 28446508 Free PMC article.
Targetable T-type Calcium Channels Drive Glioblastoma.
Zhang Y, Cruickshanks N, Yuan F, Wang B, Pahuski M, Wulfkuhle J, Gallagher I, Koeppel AF, Hatef S, Papanicolas C, Lee J, Bar EE, Schiff D, Turner SD, Petricoin EF, Gray LS, Abounader R. Zhang Y, et al. Among authors: petricoin ef. Cancer Res. 2017 Jul 1;77(13):3479-3490. doi: 10.1158/0008-5472.CAN-16-2347. Epub 2017 May 16. Cancer Res. 2017. PMID: 28512247 Free PMC article.
Protein network construction using reverse phase protein array data.
Varghese RS, Zuo Y, Zhao Y, Zhang YW, Jablonski SA, Pierobon M, Petricoin EF, Ressom HW, Weiner LM. Varghese RS, et al. Among authors: petricoin ef. Methods. 2017 Jul 15;124:89-99. doi: 10.1016/j.ymeth.2017.06.017. Epub 2017 Jun 24. Methods. 2017. PMID: 28651964 Free PMC article.
DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial.
Wolf DM, Yau C, Sanil A, Glas A, Petricoin E, Wulfkuhle J, Severson TM, Linn S, Brown-Swigart L, Hirst G, Buxton M, DeMichele A, Hylton N, Symmans F, Yee D, Paoloni M, Esserman L, Berry D, Rugo H, Olopade O, van 't Veer L. Wolf DM, et al. NPJ Breast Cancer. 2017 Aug 25;3:31. doi: 10.1038/s41523-017-0025-7. eCollection 2017. NPJ Breast Cancer. 2017. PMID: 28948212 Free PMC article.
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study.
Ludovini V, Chiari R, Tomassoni L, Antonini C, Baldelli E, Baglivo S, Siggillino A, Tofanetti FR, Bellezza G, Hodge KA, Petricoin E, Pierobon M, Crinò L, Bianconi F. Ludovini V, et al. Oncotarget. 2017 Jun 14;8(47):83343-83353. doi: 10.18632/oncotarget.18480. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137348 Free PMC article.
Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL.
Olshen A, Wolf D, Jones EF, Newitt D, van ‘t Veer LJ, Yau C, Esserman L, Wulfkuhle JD, Gallagher RI, Singer L, Petricoin EF 3rd, Hylton N, Park CC. Olshen A, et al. Among authors: petricoin ef 3rd. J Med Imaging (Bellingham). 2018 Jan;5(1):011014. doi: 10.1117/1.JMI.5.1.011014. Epub 2017 Dec 23. J Med Imaging (Bellingham). 2018. PMID: 29296631 Free PMC article.
Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice.
Blohm-Mangone K, Burkett NB, Tahsin S, Myrdal PB, Aodah A, Ho B, Janda J, McComas M, Saboda K, Roe DJ, Dong Z, Bode AM, Petricoin EF 3rd, Calvert VS, Curiel-Lewandrowski C, Alberts DS, Wondrak GT, Dickinson SE. Blohm-Mangone K, et al. Among authors: petricoin ef 3rd. Cancer Prev Res (Phila). 2018 May;11(5):265-278. doi: 10.1158/1940-6207.CAPR-17-0349. Epub 2018 Feb 1. Cancer Prev Res (Phila). 2018. PMID: 29437671 Free PMC article.
Correction: Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection.
de la Fuente C, Pinkham C, Dabbagh D, Beitzel B, Garrison A, Palacios G, Hodge KA, Petricoin EF, Schmaljohn C, Campbell CE, Narayanan A, Kehn-Hall K. de la Fuente C, et al. Among authors: petricoin ef. PLoS One. 2018 Mar 15;13(3):e0194633. doi: 10.1371/journal.pone.0194633. eCollection 2018. PLoS One. 2018. PMID: 29543894 Free PMC article.
400 results